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OBJECTIVES We report short-term findings in 33 patients after transcatheter closure (TCC) of coronary
artery fistulae (CAF) and compare our results with those reported in the recent transcatheter
and surgical literature.
BACKGROUND Transcatheter closure of CAF has been advocated as a minimally invasive alternative to
surgery.
METHODS We reviewed all patients presenting with significant CAF between January 1988 and August
2000. Those with additional complex cardiac disease requiring surgical management were
excluded.
RESULTS Of 39 patients considered for TCC, occlusion devices were placed in 33 patients (85%) at 35
procedures and included coils in 28, umbrella devices in 6 and a Grifka vascular occlusion
device in 1. Post-deployment angiograms demonstrated complete occlusion in 19, trace in 11,
or small residual flow in 5. Follow-up echocardiograms (median, 2.8 years) in 27 patients
showed no flow in 22 or small residual flow in 5. Of the 6 patients without follow-up imaging,
immediate post-deployment angiograms showed complete occlusion in 5 or small residual
flow in 1. Thus, complete occlusion was accomplished in 27 patients (82%). Early
complications included transient ST-T wave changes in 5, transient arrhythmias in 4 and
single instances of distal coronary artery spasm, fistula dissection and unretrieved coil
embolization. There were no deaths or long-term morbidity. Device placement was not
attempted in 6 patients (15%), because of multiple fistula drainage sites in 4, extreme vessel
tortuosity in 1 and an intracardiac hemangioma in 1.
CONCLUSIONS A comparison of our results with those in the recent transcatheter and surgical literature
shows similar early effectiveness, morbidity and mortality. From data available, TCC of CAF
is an acceptable alternative to surgery in most patients. (J Am Coll Cardiol 2002;39:
1026–32) © 2002 by the American College of Cardiology Foundation
Coronary artery fistulae (CAF) are rare anomalies, com-
monly diagnosed through evaluation of a continuous mur-
mur in an asymptomatic child. Elective closure in childhood
has been recommended (1–3) after reports that patients
with CAF may develop complications such as myocardial
ischemia, congestive heart failure, endocarditis or aneurys-
mal dilation during or after the second decade of life (4,5).
Transcatheter closure (TCC) of CAF has been utilized
since 1983 (4,6–15). Prior reports, including our own (14),
have been limited in patient number (2 to 13 patients) and
follow-up data (longest mean follow-up, 1.5 years). Begin-
ning in 1988, our institutional approach has been to attempt
TCC in all patients presenting with clinically significant,
isolated CAF. We present our experience to: 1) describe the
techniques used in TCC of CAF; 2) report our results with
this procedure; 3) compare our findings with those de-
scribed in the transcatheter and recent surgical literature;
and 4) outline our current indications for surgical or TCC of
CAF.
METHODS
Patient identification, selection and classification. From
our medical and surgical databases, we identified all patients
with CAF who underwent a catheterization or surgical
procedure between January 1988 and August 2000. After
exclusion of those with additional complex cardiac disease
requiring surgical management, and of those with tiny CAF
found incidentally during echocardiography or catheteriza-
tion, we identified 39 patients with clinically significant
CAF (i.e., those producing symptoms or a typical murmur).
Of the 39 patients, TCC was undertaken in 33 (TCC
patient group) but not attempted in 6 patients (non-
intervention patient group).
Clinical, electrocardiogram and echocardiographic as-
sessment. All patients underwent a cardiac evaluation,
including medical history, physical examination, electrocar-
diogram (ECG) and echocardiogram. Echocardiographic
features indicating a significant CAF included (one or
more) the following: cardiac chamber dilation; narrowest
color Doppler flow jet 4 mm; or reversal of flow in the
descending aorta.
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Transcatheter closure technique. Femoral arterial and
venous catheters were placed via percutaneous access. After
collection and analysis of hemodynamic data, the anatomy
and dimensions of the coronary arteries and fistulae were
determined using selective (often power-assisted) coronary
angiograms. Hand injections of contrast facilitated catheter
positioning in the distal fistula. Due to the typically high
flow rates in CAF, balloon occlusion angiography was used
within the fistula to precisely identify all distal coronary
branches, fistula dimensions and drainage sites. Catheter
positioning within the distal fistula was often facilitated by
the use of high-torque floppy wires or tracker catheters
(Tracker Infusion Catheter, Medi-tech/Boston Scientific
Corp., Watertown, Massachusetts), as reported by other
investigators (16,17).
Feasibility of closure by a device was determined by the
number and location of drainage sites, the ability to cannu-
late the distal fistula and the proximity of coronary branches
to the optimal occlusion site. Special care was taken to avoid
allowing the device to interfere with flow into any visible
coronary artery. Occlusion devices included Gianturco coils
(Occluding Spring Emboli; Cook Cardiology; Blooming-
ton, Indiana), double umbrella devices (Bard PDA Um-
brella, Bard Clamshell Septal Umbrella, USCI Division,
C.R. Bard; CardioSEAL: Nitinol Med Techn Inc.; Boston,
Massachusetts) and Gianturco Grifka vascular occlusion
device (GGVOD: Cook Cardiology; Bloomington, Indi-
ana). The selection of occlusion device was based on the
anatomic features of the fistula. Coils, used primarily in
smaller CAF (Fig. 1), offer advantages of smaller sheath and
catheter delivery sizes and lower cost. Double umbrella
devices allow more precise positioning and were used in
larger fistulae with coronary branches close to the occlusion
site.
To occlude the distal fistula immediately proximal to the
drainage site, we selected coils 20% to 40% larger than the
maximum diameter of the vessel. To occlude the drainage
orifice into a cardiac chamber by straddling this site, we
selected coils or double umbrella devices approximately
twice the diameter of that orifice. Device deployment was
performed either antegrade (via the femoral vein) or retro-
grade (via the femoral artery). Antegrade deployment avoids
potential damage to the femoral artery, allows use of larger
catheters and affords a straighter catheter course. An arte-
riovenous wire loop to allow TCC from either approach
(Fig. 2) was created where feasible by first guiding a catheter
through the fistula via the aorta, then passing a wire via this
catheter into the right heart, where it was snared and
extracted via the femoral vein.
Follow-up. Medical records including echocardiograms
and ECGs were reviewed. The presence and degree of
residual flow after TCC were determined by the most recent
echocardiographic data. When follow-up echocardiograms
were not performed, the most recent clinical data in con-
junction with the angiographic results at the conclusion of
TCC were used.
Data analysis. Medical records including clinical evalua-
tions, catheterization, ECG and echocardiographic and
follow-up data were reviewed in all patients. Approval to
conduct the medical record review was obtained from our
Institutional Review Board.
RESULTS
Transcatheter closure patient group. Thirty-nine patients
(age, 8 months to 68 years; median age, 8 years) underwent
cardiac catheterization with the intent to close the CAF.
Occlusion devices were placed in 33 patients (85%). Of
these, two patients underwent a second catheterization for
significant residual fistulae, resulting in a total of 35 proce-
dures. Additional cardiac lesions were present in six pa-
tients, consisting of atrial arrhythmias in two patients and
single instances of pulmonary atresia post Fontan procedure,
Abbreviations and Acronyms
CAF  coronary artery fistulae
Cx  circumflex
ECG  electrocardiogram
LAD  left anterior descending
LCA  left coronary artery
LV  left ventricle
RA  right atrium
RCA  right coronary artery
RV  right ventricle
TCC  transcatheter closure
Figure 1. Coronary artery fistula from right coronary artery to right atrium.
(A) Single insertion site into right atrium (arrow). (B) Complete occlusion
following transvenous placement of single coil (arrow).
Figure 2. Coronary artery fistula from left coronary artery to left atrium.
(A) Arteriovenous wire loop enabling passage of venous catheter across the
atrial septum into the fistula drainage site (arrow). (B) Angiogram
following transvenous deployment of a 12-mm Rashkind device (arrow),
showing coronary artery fistula occlusion and coronary artery side branches
that were not evident in angiograms performed without balloon occlusion.
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aortic stenosis post Ross procedure, post heart transplant
and a single left coronary artery (LCA). Thirteen patients
(39%) were symptomatic (dyspnea on exertion, 8; chest
pain, 3; palpitations, 1; and fatigue, 1). Continuous mur-
murs were present in 31 patients and systolic murmurs in 2.
Pre-catheterization ECGs were normal in 25 of the 33
patients (76%), with left ventricular (LV) hypertrophy
evident in 4, non-specific ST-T wave changes in 3 and right
atrial (RA) enlargement in 1.
The sites of CAF origin and drainage are detailed in
Figure 3. Origin from the LCA was more common than
from the right, and drainage to the right heart occurred in
all but two. Fistulae originated from two coronary arteries in
two patients and had multiple drainage sites in three others.
At 35 catheterizations (33 patients), coils were placed in
28 procedures, Rashkind or CardioSEAL devices in 6, and
a Grifka vascular occlusion device in the other (Fig. 4).
Nineteen devices were deployed retrograde and 16 ante-
grade; an arteriovenous wire loop facilitated antegrade
delivery in 11 patients. In five patients, tracker catheters
facilitated distal positioning of coils within long and tortu-
ous fistulae.
Immediate post-deployment angiograms (Fig. 5) demon-
strated complete occlusion in 19, trace (barely perceptible)
flow in 11 and small residual flow in five. A second
catheterization for TCC of significant residual fistulae was
performed in two patients; in the first, angiography showed
trace residual flow immediately after placement of a 12-mm
umbrella device; but six months later, a continuous murmur
was noted, and echocardiography revealed significant resid-
ual flow. At re-catheterization, eight coils placed within the
fistula resulted in complete occlusion both angiographically
and on follow-up echocardiography. In the second patient,
implantation of two 17-mm CardioSEAL devices at two
drainage sites into the RA resulted in trace residual flow
angiographically. A continuous murmur was noted at
follow-up, and echocardiography showed significant resid-
ual flow. At re-catheterization, 11 coils placed within the
fistula resulted in trace residual flow by angiography and
follow-up echocardiography. In both patients the continu-
ous murmurs were absent at follow-up.
Procedural complications included transient ST-T wave
changes in five, transient atrial arrhythmia in four, and
single instances of distal coronary artery spasm with contrast
injection, unretrieved embolized coil to a pulmonary artery
and fistula dissection. In the latter, the dissection occurred
at the site of coil implantation, was followed by fistula
thrombosis and was without sequelae. There were no
deaths, strokes or infections. Electrocardiograms were avail-
able after 29 procedures and were unchanged from baseline
Figure 3. The transcatheter closure patient group: coronary artery fistulae
origin and drainage sites. Circ  circumflex artery; CS  coronary sinus;
LA  left atrium; LAD  left anterior descending coronary artery;
LMCA left main coronary artery; LV  left ventricle; PA  pulmonary
artery; RA  right atrium; RCA  right coronary artery; RCC  right
coronary cusp; RV  right ventricle; RVOT  right ventricular outflow
tract; SVC  superior vena cava.
Figure 4. Device delivery in the transcatheter closure patient group. (A) Occlusion device used. (B) Catheter approach for device delivery.
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in 24 with transient ST-T wave changes noted in five
patients.
Non-intervention patient group. Placement of an occlu-
sion device was not attempted in 6 (15%) of the 39 patients
initially considered for TCC, all but one catheterized early
in our experience (1988 to 1993). These patients ranged in
age from 3 weeks to 48 years (median age, 4 years) at
catheterization; additional cardiac lesions were present in
three patients, consisting of a single LCA in two and
intracardiac hemangioma in the other. One patient was
symptomatic; all had continuous murmurs. The sites of
CAF origin and drainage are detailed in Table 1. Placement
of a device was not attempted due to the presence of
multiple fistula drainage sites in four, extreme vessel tortu-
osity with inability to cannulate the distal fistula (Fig. 6) in
one and the presence of multiple minute drainage sites from
an intracardiac hemangioma in the other. There were no
immediate or late complications.
Follow-up. TCC PATIENT GROUP. At follow-up (median,
2.8 years; range, 1 month to 11.1 years), all patients were
asymptomatic, and 30 were without continuous murmurs.
The most recent echocardiograms, available in 27 patients,
identified complete occlusion in 22 (82%) and small residual
flow in 5 (18%) (Fig. 5). Six patients have not had follow-up
echocardiograms; of these, five had no residual flow by
angiography immediately after device placement, and the
other had a small residual shunt and a persistent continuous
murmur. Thus, complete occlusion was accomplished in 27
patients (82%).
NON-INTERVENTION PATIENT GROUP. Follow-up data
(median, 7.4 years; range, 5.8 to 11 years) were available in
only three of the six patients. They were asymptomatic: the
murmur had disappeared in the patient with an intracardiac
hemangioma, and echocardiograms, available in only two
patients, were unchanged.
DISCUSSION
Elective closure of significant CAF in childhood has been
advocated to prevent later complications (1,5,8,11). Since its
introduction in 1983 (6), TCC of these lesions is increas-
ingly being utilized as an alternative to surgical closure.
Transcatheter and surgical literature review. TCC LITERA-
TURE. Excluding single case reports, TCC of CAF has
been reported in 45 patients (5 weeks to 71 years of age;
median, 12 years) since 1982 (4,7–13,15) (Table 2). The
data from our previously published report (14) are included
in our current patient group. The fistulae were isolated
lesions in all but one (prior aortic valve replacement).
Symptoms were reported in 18 (40%), including angina in
10, dyspnea on exertion in 6 and single instances of fatigue
and poor growth. The fistulae originated from the LCA in
Figure 5. Residual flow following transcatheter closure of coronary artery fistula by angiography and echocardiography.
Table 1. Transcatheter Non-Intervention Patient Group
Patient Age Fistula Origin Fistula Drainage
Reason for No
Intervention
1 48.6 yrs RCA CS Vessel tortuosity
2 4.2 yrs LAD RV Multiple drainage sites
3 1.2 yrs LAD RV Multiple drainage sites
4 20 days RCA/LCA RA Hemangioma
5 5.0 yrs RCA RA Multiple drainage sites
6 4.0 yrs LAD/Cx RV Multiple drainage sites
CS  coronary sinus; Cx  circumflex artery; LAD  left anterior descending artery; LCA  left coronary artery; RA  right
atrium; RCA  right coronary artery; RV  right ventricle.
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24 (10 from the left anterior descending [LAD], seven from
the circumflex [Cx]), from the right coronary artery (RCA)
in 19, and from both RCA/LCA in two. Fistulae drained to
the RA in 14, right ventricle (RV) in 12, pulmonary artery
in 11, coronary sinus in 3, LV in 2, bronchial artery in 2 and
superior vena cava in 1.
Transarterial device delivery was performed in 41 proce-
dures. Coils were placed in 31, detachable balloons in 10,
umbrella devices in 2, covered stent in 1 and a combination
of detachable balloons and coils in 2. Successful occlusion of
the CAF at catheterization was reported in 83% of patients.
One patient required re-catheterization for complete clo-
sure. Procedural complications included transient ischemic
changes on ECG in four, unretrieved device embolization to
tricuspid valve or distal pulmonary artery in a similar
number and single instances of myocardial infarction and
transient atrial arrhythmia. There was one procedure-
related death (2.2%) involving a symptomatic 71-year-old
man with a large CAF arising from a diffusely diseased
LAD and inserting into a pulmonary artery. Death resulted
from embolization of a coil to the LCA and subsequent
LCA dissection (4).
At follow-up (1 day to 4 years; longest mean follow-up,
12 months) in 42 of 45 patients, all were asymptomatic and
without late complications or deaths. At follow-up imaging
studies of 33 patients (echocardiograms in 27, angiograms
in 6), complete closure was reported in 91%.
SURGICAL LITERATURE. Surgical series published in the
past decade (1–3,18–20) consisted of 71 patients (81 fistu-
lae) (Table 2). These patients ranged in age from 6 days to
77 years (median, 6 years); 19 had additional cardiac lesions
(27%), including patent ductus arteriosus in 4, atrial septal
defect and mitral regurgitation in 3 each, 2 patients each
with aortic regurgitation, tetralogy of Fallot, ventricular
septal defect, RCA origin atresia and coarctation of the
aorta in 1. Closure of CAF was performed concurrent with
additional cardiac surgical procedures in 11 patients (15%),
including valve replacement, atrial or ventricular septal
defect repair and patent ductus arteriosus ligation. The use
of cardiopulmonary bypass was reported in 37 patients
(57%). The fistulae arose from the RCA in 21 patients, the
LCA in 40 (LAD in 18, Cx in 7) and both RCA/LCA in
10. Drainage sites included the RV in 28 patients, pulmo-
nary artery in 20, RA in 18, RV outflow tract in 3 and 1 each
in the left atrium and LV. There was one operative death
(1.4%) secondary to myocardial infarction (19). Other
complications included arrhythmia in five, transient isch-
emic changes on ECG in one and stroke in another. There
were no reported late post-operative deaths. Follow-up was
available in 65 patients (range, 0.1 to 21.1 years; longest
mean follow-up, 7.2 years), and all were asymptomatic.
Follow-up imaging studies were reported in only 21 (30%)
of the 70 survivors (angiography, 13; echocardiography, 8),
with complete closure rates in these ranging from 50% to
100% (1,18,20).
Observations. The origin and drainage sites in the TCC
and surgical literature are similar to our data except for our
lower incidence of drainage to a pulmonary artery. Delivery
of the occlusion device (usually coils) was more often
performed via a retrograde approach in the transcatheter
literature (89%) compared with our series (54%). Follow-up
imaging was available in 75% of the patients reported in the
transcatheter literature, 30% of surgical patients and 82% of
patients in our series. Because of this wide disparity in
follow-up imaging data, a valid comparison of documented
closure of CAF between the techniques is difficult. How-
ever, given the available data, complete closure by transcath-
eter and surgical techniques are comparable, as are rates of
early and late complications (Table 2).
While we have found TCC of CAF feasible in most
patients, features that may render CAF unsuitable for this
technique include those with extreme vessel tortuosity,
multiple drainage sites and coronary branches at the site of
optimal device positioning. The ability to cannulate the
distal fistula and avoid flow interference through nearby
coronary branches is mandatory for successful TCC. Early
in our experience (prior to 1994), we determined that CAF
with multiple drainage sites precluded an attempt at TCC;
however, with experience and improvements in catheteriza-
tion equipment and occlusion devices, we have subsequently
successfully closed fistulae with this characteristic in three
patients.
An “ideal” study to provide a rigorous comparison of
transcatheter versus surgical therapy would necessitate a
randomized multicenter trial with fixed entry criteria, sim-
ilar operator skills at each of the institutions and an
extended period of follow-up. The technique of therapy
would need to remain largely fixed during the course of the
study. Without the data from such a trial, we have adopted
the following therapeutic strategy: 1) those with CAF and
additional complex heart disease requiring surgery are re-
ferred for surgical repair; 2) patients with a clinically
Figure 6. Angiogram showing tortuous coronary artery fistula from right
coronary artery to coronary sinus (Table 1, Patient 1): occlusion not
attempted as antegrade access to coronary artery fistula unsuccessful and
catheter lengths insufficient to reach distal fistula from a retrograde
approach.
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significant CAF (i.e., producing symptoms or a typical
murmur) are referred for catheterization, where the fistula
anatomy is further defined; 3) those with suitable anatomy
undergo TCC, while those unsuitable for TCC are offered
surgical ligation or are followed up medically.
With regard to tiny CAF now being diagnosed with
improved color flow Doppler technology, we currently, as
do other investigators (20,21), follow such patients without
intervening, because the incidence of cardiac complications
is low and there is the possibility of spontaneous closure.
There are others, however, who disagree with this strategy
(5,22).
Study limitations. A meaningful comparison of transcath-
eter and surgical closure of CAF is limited by (a) small
patient numbers and (b) the paucity of follow-up imaging,
especially in the surgical literature. Additionally, although
we have limited our review of the surgical literature to series
that were published within the past decade, each of these
includes patients treated prior to this period.
CONCLUSIONS
With increased experience and improved devices and tech-
niques, TCC of CAF is emerging as a successful therapeutic
strategy. The safe and effective results of both surgical
closure and TCC support the current convention of elective
closure of clinically significant CAF in childhood. The
preferred method of approach for any individual patient will
depend on the anatomy of the fistula, the presence or
absence of associated defects and the experience of the
interventional cardiologists and surgeons.
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